Most beginner peptide guides hand you a compound list and say good luck. No foundation check. No sequencing logic. No explanation of what to evaluate and when. This is the guide that fills that gap, because what you run first matters far less than whether your system is ready to benefit from it.
If you are researching peptides for the first time, the volume of information is overwhelming. Forum posts contradict each other. YouTube videos recommend stacks of four or five compounds on day one. Reddit threads treat advanced protocols like beginner advice. The result is that most new researchers either start with the wrong compound for their situation or start with the right compound on a foundation that cannot support it.
This guide covers the decision logic that the Protocol Builder uses when a new researcher runs the tool. It walks through what to check before starting any compound, how to choose the right first compound for your specific goal, what to expect during the first twelve weeks, and when adding support compounds actually becomes the rational next step instead of a premature complication.
Answer a short intake about your research goal, current situation, and foundations. The tool builds the full protocol from your specific answers, sequences compounds by layer, and checks for receptor conflicts across the full stack.
Free. No login. Run it as many times as you want.
If you want to understand the logic behind the tool before you use it, keep reading. The rest of this guide breaks down every decision the tool makes, starting with the four foundation checks and ending with the week by week timeline.
Researchers who have not yet started a peptide protocol and want to understand the right sequence of decisions before committing to a compound.
Researchers who have been reading about peptides for weeks or months and feel paralyzed by conflicting information about what to start with.
Anyone who has searched for "best peptide protocol for beginners" and found lists of compounds with no explanation of when or why each one applies.
Before You Start Any Compound
The single principle that runs through every section of this guide is this: peptides only amplify. They do not replace infrastructure. If sleep is poor, stimulants are high, stress is unmanaged, and nutrition is chaotic, every compound in this guide will amplify the chaos rather than correct it.
That is not a motivational statement. It is a mechanical one. A GH secretagogue (a compound that stimulates growth hormone release) needs quality sleep to produce a meaningful GH pulse. If sleep is fragmented, the pulse is blunted. The compound did exactly what it was designed to do in an environment that limited the effect. The researcher concludes the compound does not work. The compound worked. The environment did not.
The Protocol Builder checks four foundation variables before recommending anything. These are not lifestyle suggestions. They are protocol prerequisites.
Foundation gaps do not mean you cannot start. They mean the protocol will underperform until addressed. Fix in parallel, not after failure.
If all four foundations are solid, the compound has the best possible environment to produce the result the research predicts. If one or more are flagged, the Protocol Builder does not block the recommendation. It tells you the protocol will produce a fraction of its documented effect until the gap is resolved and gives you specific next steps to address each one.
Choosing Your First Compound
If your primary research goal is fat loss and you have not started any compounds yet, the Protocol Builder recommends semaglutide as the starting point for most new researchers. Not because it is the strongest. Not because it is the newest. Because it is the most predictable.
Semaglutide is a pure GLP-1 receptor agonist. That means it targets one receptor. It suppresses what researchers call food noise, which is the mental background pull toward eating that runs throughout the day even when you are not physically hungry. It also slows gastric emptying (how quickly food moves through the stomach), which creates a stronger feeling of fullness after meals.
One receptor, one mechanism, and the longest safety and efficacy dataset in the GLP-1 class. For a new researcher, that combination is more valuable than raw potency because it produces a readable response. When something changes on semaglutide, you know what caused it. That readability becomes the foundation for every protocol decision that follows.
| Compound | Receptors | What It Does |
|---|---|---|
| Semaglutide | GLP-1R (one receptor) | Suppresses food noise. Slows gastric emptying. Steadier blood sugar. The entire mechanism runs through one receptor, which means the side effect profile is predictable and the response is readable. |
| Tirzepatide | GLP-1R + GIPR (two receptors) | Everything semaglutide does, plus the GIP receptor which improves insulin response and nutrient handling. Research suggests tirzepatide may produce stronger early satiety with potentially better GI tolerability because two receptors share the work that semaglutide puts on one. |
| Retatrutide | GLP-1R + GIPR + GcgR (three receptors) | Everything tirzepatide does, plus the glucagon receptor which tells the body to burn stored fuel rather than just eat less. Research suggests this creates a thermogenic effect (increased energy expenditure) that the other two do not produce. The hunger pattern is different because glucagon drives a different metabolic signal. |
Why not start with the strongest option?
The progression from one receptor to two to three makes retatrutide look dominant on paper. But each additional receptor is also additional systemic load. More mechanisms working simultaneously means more variables changing at once, which makes the protocol harder to read. If something is not working at week six on retatrutide, was it the GLP-1 component, the GIP component, or the glucagon component? On semaglutide, there is only one variable to evaluate.
The other reason is that semaglutide, tirzepatide, and retatrutide are not three intensities of the same drug. They are different tools with different mechanisms. Researchers who judge retatrutide by the same hunger standard as semaglutide will misread the compound. The hunger that persists on retatrutide is often the glucagon mechanism working, not a failure of suppression. Starting with a single receptor compound teaches you how to read GLP-1 response. That skill transfers to every compound decision after it.
When tirzepatide or retatrutide makes sense as a first compound
If GI tolerability is a primary concern based on personal history, tirzepatide may be the better starting point because the dual receptor mechanism appears to reduce some of the nausea that pure GLP-1 activation produces. If the research goal includes a thermogenic component from the start and the researcher understands that the hunger pattern will feel different than traditional appetite suppression, retatrutide is a legitimate first choice. The Protocol Builder accounts for both of these situations. The default is semaglutide. The override is based on specific inputs, not preference for the newest compound.
What to Expect: Weeks 1 Through 12
Most beginner guides skip this section entirely. They tell you what to take and leave out what the experience actually feels like and what to evaluate at each stage. Understanding the timeline prevents two of the most common beginner mistakes: escalating the dose too early and adding compounds before the first one has reached steady state.
What is steady state?
Steady state means the compound has built up to a consistent circulating level in the body. For a compound with a long half life (the time it takes for half the dose to clear the system), this takes multiple doses. Semaglutide has an approximately 168 hour half life. That means it takes roughly six weekly injections before the compound reaches a stable level. Most researchers who report that their compound is not working are evaluating at week two or three, before the curve has flattened.
Evaluating before steady state is the single most common beginner error. It leads to unnecessary dose escalation, premature compound switches, and the conclusion that the compound failed when it never had the chance to reach full effect.
Change one variable. Evaluate for a defined period. Then decide whether to change another. Most researchers feel urgency and make multiple changes at once when results slow. That approach makes the protocol unreadable.
What the Three Layer System Means for Beginners
The Protocol Builder organizes every compound into one of three layers. The layers are not categories for sorting. They are a sequencing framework that determines what goes first, what goes second, and what waits until a specific signal says it is needed.
This is the difference between stacking and sequencing. Stacking is adding compounds. Sequencing is adding them in the right order, at the right time, in response to the right signal. Most forum advice optimizes for the most impressive stack on paper. The Protocol Builder optimizes for the most readable protocol in practice.
| Layer | What It Does | When to Add It |
|---|---|---|
| Layer 1 | The GLP-1 compound. It creates the primary metabolic demand by suppressing intake, and for retatrutide, increasing energy expenditure. Everything else in the protocol responds to what this layer produces. | This is your starting point. Week one. Nothing else runs until this compound is established. |
| Layer 2 | GH secretagogue compounds that support growth hormone output. These protect lean mass during the caloric deficit that Layer 1 creates. Two options: CJC-1295 no DAC paired with Ipamorelin, or Tesamorelin paired with Ipamorelin. Both work through the same receptor, so you choose one, not both. | Weeks four to six if lean mass is a concern. This is prevention, not correction. Requires consistent training to produce a meaningful result. |
| Layer 3 | Support and repair compounds that address specific emerging problems. BPC-157 for tissue repair and gut issues. MOTS-c for cellular energy. KPV for GI inflammation. These are response tools, not preemptive additions. | After week six to eight, only in response to a specific identified problem. If nothing is wrong, nothing gets added. |
The most important takeaway for beginners is that Layer 1 runs alone for the first four weeks minimum. The compound needs time to reach steady state. The researcher needs time to learn how to read the response. Adding two or three compounds on day one makes it impossible to determine which compound produced which effect and which compound caused which side effect.
The free protocol check maps your current compounds to the bottleneck they were built to solve. If the bottleneck has already been addressed, it flags it. Before adding a second compound, knowing which variable is actually limiting the result is the more useful starting point than assuming more is better.
Run the Free Protocol CheckWhat to Wait On and Why
The hardest part of a beginner protocol is not starting. It is resisting the urge to add everything at once. The research community has a bias toward complexity. The more compounds in the stack, the more serious the protocol looks. But complexity without sequencing is not a protocol. It is noise.
Here is what to wait on and why each compound earns its place through a specific trigger, not a calendar date.
GH secretagogues: wait for the right window
CJC-1295 no DAC paired with Ipamorelin, or Tesamorelin paired with Ipamorelin, are the most common Layer 2 additions. Both support growth hormone output to protect lean mass during a deficit. The reason to wait until week four to six is that the Layer 1 compound needs to reach steady state first. Adding a GH secretagogue on day one introduces two new mechanisms simultaneously. If nausea appears, was it the GLP-1 or the secretagogue? If sleep changes, which compound caused it? Sequencing answers those questions before they become diagnostic problems.
There is also a foundation requirement. GH secretagogues need a training stimulus to act on. Without consistent resistance training, the growth hormone pulse has nothing to build. The Protocol Builder will not recommend a Layer 2 addition to a researcher who is not training.
Repair compounds: wait for a reason
BPC-157 and TB-500 are tissue repair compounds. BPC-157 works locally through anti-inflammatory and blood vessel formation pathways. TB-500 works systemically through cell migration and recovery signaling. They are a known pairing and often used together. But unless a specific injury or gut issue is present, there is no reason to run them from day one. They are response tools. The trigger is a problem, not a protocol start date.
Energy compounds: wait for the right phase
MOTS-c is a mitochondrial peptide that improves how efficiently cells produce energy. SS-31 stabilizes the mitochondrial membrane. Both address energy decline, but energy decline is not a beginner problem. It is a Phase 2 or Phase 3 problem that emerges after the body has adapted to sustained caloric restriction. Adding an energy compound in week one when intake is still the primary variable does not solve the problem that compound was built for. In some cases it may increase the demand for fuel through better energy processing before the intake system is under control.
The compound that does not belong in a beginner stack at all
SLU-PP-332 appears in research discussions frequently. It activates a pathway that improves fuel efficiency during physical output. Endurance increases. Fat oxidation improves during exercise. None of that addresses intake control. If hunger is still the limiting variable, which it is for most beginners, SLU-PP-332 will not move the needle. This compound belongs in the late phase of a protocol when intake is stable and the limiter has shifted to output efficiency.
The Mistakes That Cost Beginners the Most Time
Every one of these is fixable. Most are preventable with the right framework. The Protocol Builder is designed to catch all five before they happen.
What the Protocol Builder Handles For You
Everything in this blog post is the logic that runs inside the Protocol Builder. The tool asks about your research goal, where you are in your research timeline, which compounds you are running if any, your foundations, and your specific concerns. Then it sequences compounds by layer, checks for receptor conflicts across the full stack, and produces a timing framework so you know when to introduce each addition and why.
For a new researcher who has not started any compounds, the tool builds the protocol from scratch. Foundation checks first, then a Layer 1 recommendation based on your primary goal, then conditional Layer 2 and Layer 3 additions based on what problems emerge during the protocol.
The difference between this guide and the tool is that the guide explains the logic and the tool applies it to your specific situation. Both are free. The guide gives you the understanding. The tool gives you the output.
Full stack visualizer with receptor overlap detection. Deep bottleneck analysis with compound-specific routing. 50+ research deep dives. The complete guide library. One membership.
See What Members GetFor educational and research purposes only | Not medical advice | Not for human use guidance | Project Theo